Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Duan EH"" wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł:
Scale-up and sustainability of a personalized end-of-life care intervention: a longitudinal mixed-methods study.
Autorzy:
Takaoka A; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Tam B; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Vanstone M; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
Clarke FJ; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Hoad N; Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.
Swinton M; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Toledo F; Department of Spiritual Care, St Joseph's Healthcare, Hamilton, Ontario, Canada.
Boyle A; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Palliative Care, St Joseph's Healthcare, Hamilton, Ontario, Canada.
Woods A; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Palliative Care, St Joseph's Healthcare, Hamilton, Ontario, Canada.
Duan EH; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.
Heels-Ansdell D; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Waugh L; Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.
Soth M; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.
Rudkowski J; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.
Alhazzani W; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.
Perri D; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.
Ligori T; Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.; Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada.
Jaeschke R; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.
Zytaruk N; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Cook DJ; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada. .; Department of Medicine, McMaster University, Hamilton, Ontario, Canada. .; Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada. .
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2021 Mar 10; Vol. 21 (1), pp. 218. Date of Electronic Publication: 2021 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
Hospice Care*
Terminal Care*
Family ; Focus Groups ; Humans ; Intensive Care Units
Czasopismo naukowe
Tytuł:
Protocol adherence for continuously titrated interventions in randomized trials: an overview of the current methodology and case study.
Autorzy:
Lauzier F; Department of Medicine, Université Laval, Québec, Québec, Canada.; Department of Anesthesiology and Critical Care Medicine, Université Laval, Québec, Québec, Canada.; Centre de recherche du CHU de Québec-Université Laval, Axe Santé des Populations et Pratiques Optimales en Santé, Québec, Québec, Canada.
Adhikari NK; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Seely A; Thoracic Surgery and Critical Care Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Koo KKY; Swedish Medical Group, Seattle, Washington, USA.; Department of Medicine, Western University, London, Ontario, Canada.
Belley-Côté EP; Departments of Medicine, Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada.; Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Burns KEA; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Cook DJ; Departments of Medicine, Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada.
D'Aragon F; Department of Anaesthesiology, Université de Sherbrooke, Québec, Canada.; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.
Rochwerg B; Departments of Medicine, Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Kho ME; School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada.
Oczkowksi SJW; Departments of Medicine, Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Duan EH; Departments of Medicine, Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Meade MO; Departments of Medicine, Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Day AG; Kingston General Hospital Research Institute, Kingston, Ontario, Canada.
Lamontagne F; Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada. .; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada. .
Pokaż więcej
Corporate Authors:
for ACCADEMY (Academy of Critical Care – Development, Evaluation, and Methodology)
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2017 Jul 17; Vol. 17 (1), pp. 106. Date of Electronic Publication: 2017 Jul 17.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Protocols*
Patient Compliance*
Randomized Controlled Trials as Topic/*standards
Research Design/*standards
Arterial Pressure/drug effects ; Humans ; Hypotension/drug therapy ; Hypotension/etiology ; Pilot Projects ; Randomized Controlled Trials as Topic/methods ; Shock/complications ; Vasoconstrictor Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial-PROSPECT: a pilot trial.
Autorzy:
Cook DJ; Department of Medicine, McMaster University, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, ON, Canada. .; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada. .
Johnstone J; Public Health Ontario, Toronto, ON, Canada.; St. Joseph's Health Center, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Marshall JC; Department of Surgery, University of Toronto, Toronto, ON, Canada.; Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada.
Lauzier F; Research Center of the CHU de Québec - Population Health and Optimal Health Practices Research Unit, Université Laval, Quebec City, QC, Canada.; Department of Medicine, Université Laval, Quebec City, QC, Canada.; Department of Anesthesiology and Critical Care, Université Laval, Quebec City, QC, Canada.
Thabane L; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
Mehta S; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada.
Dodek PM; Division of Critical Care Medicine, St. Paul's Hospital and University of British Columbia, Vancouver, BC, Canada.; Center for Health Evaluation and Outcome Sciences, St. Paul's Hospital and University of British Columbia, Vancouver, BC, Canada.
McIntyre L; Division of Critical Care, University of Ottawa, Ottawa, ON, Canada.
Pagliarello J; Division of Critical Care, University of Ottawa, Ottawa, ON, Canada.
Henderson W; Division of Critical Care Medicine, Vancouver General Hospital, Vancouver, BC, Canada.
Taylor RW; Department of Critical Care Medicine, Mercy Hospital, St Louis, MO, USA.
Cartin-Ceba R; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Golan E; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada.
Herridge M; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada.
Wood G; Department of Anesthesia & Critical Care, Vancouver Island Health Authority, Victoria, BC, Canada.
Ovakim D; Department of Anesthesia & Critical Care, Vancouver Island Health Authority, Victoria, BC, Canada.
Karachi T; Department of Medicine, McMaster University, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, ON, Canada.
Surette MG; Department of Medicine, McMaster University, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, ON, Canada.
Bowdish DM; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Lamarche D; Biochemistry and Biomedical Sciences Department, McMaster University, Hamilton, ON, Canada.
Verschoor CP; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Duan EH; Department of Medicine, McMaster University, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, ON, Canada.
Heels-Ansdell D; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
Arabi Y; King Saud Bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Meade M; Department of Medicine, McMaster University, McMaster Health Sciences Center, Room 2C11, 1200 Main Street W, Hamilton, ON, Canada.; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
Pokaż więcej
Corporate Authors:
PROSPECT Investigators and the Canadian Critical Care Trials Group
Źródło:
Trials [Trials] 2016 Aug 02; Vol. 17, pp. 377. Date of Electronic Publication: 2016 Aug 02.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Intubation, Intratracheal/*adverse effects
Lacticaseibacillus rhamnosus/*growth & development
Pneumonia, Bacterial/*prevention & control
Pneumonia, Ventilator-Associated/*prevention & control
Probiotics/*administration & dosage
Trachea/*microbiology
Adult ; Aged ; Canada ; Feasibility Studies ; Female ; Hospital Mortality ; Humans ; Intensive Care Units ; Intubation, Intratracheal/mortality ; Length of Stay ; Male ; Middle Aged ; Pilot Projects ; Pneumonia, Bacterial/diagnosis ; Pneumonia, Bacterial/microbiology ; Pneumonia, Bacterial/mortality ; Pneumonia, Ventilator-Associated/diagnosis ; Pneumonia, Ventilator-Associated/microbiology ; Pneumonia, Ventilator-Associated/mortality ; Probiotics/adverse effects ; Severity of Illness Index ; Time Factors ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł:
Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition.
Autorzy:
Jones RB; Department of Immunology, University of Toronto, Medical Sciences Building, Toronto, Ontario, Canada. />Garrison KE
Wong JC
Duan EH
Nixon DF
Ostrowski MA
Pokaż więcej
Źródło:
PloS one [PLoS One] 2008 Feb 06; Vol. 3 (2), pp. e1547. Date of Electronic Publication: 2008 Feb 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genome, Human*
Long Interspersed Nucleotide Elements/*drug effects
Retroelements/*drug effects
Reverse Transcriptase Inhibitors/*adverse effects
Drug Evaluation ; Drug-Related Side Effects and Adverse Reactions ; Humans ; Long Interspersed Nucleotide Elements/genetics ; Nucleosides/adverse effects ; Nucleosides/chemistry ; Reverse Transcriptase Inhibitors/chemistry
Czasopismo naukowe
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies